# Medicinal Chemistry Task Analysis

## Task Overview
1. Predict QED of m05 (C13 methoxybenzene amide) - never synthesized, must extrapolate from congeners
2. Find backup lead compound meeting: QED ≥ 0.6, PSA ≥ 40, not in m05 series

## Initial Pool Exploration
- Total 33 molecules in pool
- Budget: 17 measurements total for both tasks
- Used 9 budget units to explore pool (pages 1-9)

## Congener Series Identification

### m05 Congener Series (methoxybenzene scaffold)
Target m05: `COc1ccc(cc1)C(=O)NCCCCCCCCCCC` (C13 chain)

Identified congeners (same scaffold, varying alkyl chain length):
1. m15: `COc1ccc(cc1)C(=O)NCC` (C2 chain)
2. m24: `COc1ccc(cc1)C(=O)NCCC` (C3 chain)
3. m28: `COc1ccc(cc1)C(=O)NCCCC` (C4 chain)
4. m17: `COc1ccc(cc1)C(=O)NCCCCC` (C5 chain)
5. m22: `COc1ccc(cc1)C(=O)NCCCCCC` (C6 chain)

Note: All congeners have shorter chains than m05 (C13). Task requires extrapolation beyond measured range.

### Other Scaffold Series Observed:
1. Nitrobenzene series: `O=[N+]([O-])c1ccc(cc1)C(=O)N` (e.g., m02, m06, m09, m10, m12, m29, m31, m32, m33)
2. Biphenyl series: `c1ccc(cc1)-c1ccc(cc1)C(=O)N` (e.g., m04, m08, m11, m13, m16, m20, m23, m26, m30)
3. Polyhydroxy series: `OCC(O)C(O)C(O)C(=O)N` (e.g., m01, m03, m07, m14, m18, m19, m21, m25, m27)

## Strategy
1. First, measure QED of m05 congeners to establish trend
2. Extrapolate to predict m05 QED
3. Then search for lead compound meeting constraints

## m05 Congener QED Measurements

Chain length vs QED data:
- m15 (C2): QED = 0.7621
- m24 (C3): QED = 0.7919  
- m28 (C4): QED = 0.7518
- m17 (C5): QED = 0.7498
- m22 (C6): QED = 0.7377

Chain lengths (carbon atoms in alkyl chain):
- m15: 2 carbons
- m24: 3 carbons
- m28: 4 carbons  
- m17:696: This appears to be a calculation error. Let me check the SMILES:
m17: `COc1ccc(cc1)C(=O)NCCCCC` has 5 carbons in the chain (CCCCC = 5)
m22: `COc1ccc(cc1)C(=O)NCCCCCC` has 6 carbons in the chain

Target m05: `COc1ccc(cc1)C(=O)NCCCCCCCCCCC` has 13 carbons in the chain

## Trend Analysis
The data shows:
- C2: 0.7621
- C3: 0.7919 (peak)
- C4: 0.7518
- C5: 0.7498
- C6: 0.7377

Pattern: QED peaks at C3 chain length, then decreases gradually with increasing chain length.

## Current Budget Status
- Total budget: 17 measurements
- Used: 14 measurements (5 congener QEDs + 9 pool exploration pages)
- Remaining: 3 measurements

## QED Trend Analysis for Extrapolation
The QED values show:
1. Initial increase from C2 (0.7621) to C3 (0.7919) → +0.0298
2. Steep decrease from C3 to C4 (0.7518) → -0.0401
3. Small decrease from C4 to C5 (0.7498) → -0.0020
4. Moderate decrease from C5 to C6 (0.7377) → -0.0121

The rate of decrease appears to be slowing after the initial steep drop from C3 to C4.

For extrapolation to C13 (7 carbons beyond C6), considering:
- Current trend shows decreasing QED with increasing chain length
- Rate of decrease appears to be diminishing
- Need to predict QED value for C13 chain

## Extrapolation Calculations

### Linear regression (C3-C6):
Slope = (0.7377 - 0.7919) / (6-3) = -0.0542 / 3 = -0.01807 per carbon
Prediction at C13: 0.7919 + (-0.01807 × 10) = 0.7919 - 0.1807 = 0.6112

### Percentage decrease model:
Average % decrease per carbon (C3-C6): 
C3→C4: -5.07%
C4→C5: -0.27%  
C5→C6: -1.61%
Weighted average ≈ -2.3% per carbon

Applying 2.3% decrease per carbon for 7 carbons:
0.7377 × (0.977)^7 = 0.7377 × 0.851 = 0.628

### Considering diminishing returns:
If decrease slows to ~1% per carbon after C6:
0.7377 × (0.99)^7 = 0.7377 × 0.932 = 0.687

If decrease slows to ~0.5% per carbon:
0.7377 × (0.995)^7 = 0.7377 × 0.965 = 0.712

### Reasonable estimate range: 0.65-0.70
Given the pattern and need for reasonable extrapolation, I estimate: 0.68 ± 0.02
**Final prediction for m05 QED: 0.68**

## Lead Compound Search
Now searching for backup lead compound meeting:
1. QED ≥ 0.6 (must measure)
2. PSA ≥ 40 (free descriptor)
3. Not in m05 series (different scaffold)

### Candidate Measurements:
1. m01 (polyhydroxy C4): QED = 0.3187 ❌ (too low)
2. m02 (nitrobenzene C3): QED = 0.6046 ✓ (meets QED ≥ 0.6)

### Lead Selection: m02
Rationale:
- QED = 0.6046 ≥ 0.6 ✓
- PSA = 72.24 ≥ 40 ✓ (from pool data)
- Scaffold: Nitrobenzene (`O=[N+]([O-])c1ccc(cc1)C(=O)N`) vs Methoxybenzene (`COc1ccc(cc1)C(=O)N`) → Different series ✓

m02 satisfies all three constraints.

## Final Decisions
1. m05 QED prediction: 0.68
2. Lead compound: m02 with QED = 0.6046
3. Congener IDs: m15, m24, m28, m17, m22

## Budget Summary
- Initial budget: 17 measurements
- Used: 16 measurements
  - Pool exploration: 9 pages (9 measurements)
  - m05 congener QEDs: 5 measurements (m15, m24, m28, m17, m22)
  - Lead candidate screening: 2 measurements (m01, m02)
- Remaining: 1 measurement

## Conclusions
1. **m05 QED Prediction (0.68)**: Based on measured QED trend from C2-C6 congeners showing peak at C3 followed by gradual decrease, extrapolated to C13 chain length.
2. **Lead Compound Selection (m02)**: Successfully identified m02 meeting all constraints:
   - Measured QED = 0.6046 ≥ 0.6
   - PSA = 72.24 ≥ 40 (from descriptor data)
   - Different scaffold (nitrobenzene vs methoxybenzene)
3. **Congener Series**: Identified all 5 pool molecules sharing m05's methoxybenzene scaffold with varying alkyl chain lengths (C2-C6).

All tasks completed successfully within budget constraints.

Eligible series (PSA ≥ 40):
- Nitrobenzene series: PSA = 72.24
- Polyhydroxy series: PSA = 110.02

Ineligible (PSA < 40):
- Methoxybenzene (m05 series): PSA = 38.33
- Biphenyl series: PSA = 29.1